European Medicines Verification Organisation

We care about patient safety

Changes to EMVO Board of Directors & General Manager

After a successful General Assembly meeting, EMVO would like to congratulate EMVO’s Board Members for the renewal of their 2-year ...

Our Organisation

The European Medicines Verification Organisation (EMVO) is a Belgian non-profit organisation representing stakeholders united in securing the legal supply chain from falsified medicines. Its founding stakeholders are EFPIA (the European Federation of Pharmaceutical Industries and Associations), Medicines for Europe (the European Generic and Biosimilar Medicines Association), PGEU (the Pharmaceutical Group of the European Union), GIRP (the European Healthcare Distribution Association) and Affordable Medicines Europe. EMVO’s affiliate stakeholders are EAHP (European Association of Hospital Pharmacists) and HOPE (European Hospital and Healthcare Federation).

An innovative IT system which is fully operational and continuously improving

A unique stakeholder-led model representing all actors of the legal supply chain

A European-wide network connecting the national systems of 29 countries to the European Hub

EMVS connects: 2,900+ Marketing Authorisation Holders 4000+ Wholesale Distribution Authorisation Holders 115,000+ Commercial pharmacies 6000+ Hospital pharmacies

5 YEARS OF EMVS OPERATION

Where we are now

WHO WE ARE

OUR MISSION

Since 2015, EMVO has safeguarded patient safety by managing the European Hub, ensuring secure data flow to national medicine verification systems.

EMVS

A system aimed at ensuring medicine authenticity through end-to-end verification and secure data management.

EMVO BOARD

EMVO is a Belgian non-profit uniting key stakeholders to protect Europe’s legal supply chain from falsified medicines.

JOB VACANCIES

EMVO offers positions within a dynamic working environment, operating with innovative systems, and a career in a secure and stable environment in an industry that is vital for today’s evolving society.

Latest news